Who makes Growth hormone - LB03002?

Growth hormone - LB03002 is developed by LG Life Sciences.

What development phase is Growth hormone - LB03002 in?

Growth hormone - LB03002 is in Phase 3.

Last reviewed 2026-04-20 · How we verify

Growth hormone - LB03002

LG Life Sciences · Phase 3 active Small molecule Quality 0/100

At a glance

Generic name	Growth hormone - LB03002
Sponsor	LG Life Sciences
Modality	Small molecule
Phase	Phase 3

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Treatment of Adults With Growth Hormone Deficiency (PHASE3)
Treatment of Adults With Growth Hormone Deficiency (PHASE3)
Treatment of Children With Insufficient Secretion of Growth Hormone (PHASE3)
Sustained Release Formulation of Somatropin (rDNA Origin)for Injection (PHASE2, PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Growth hormone - LB03002 CI brief — competitive landscape report
Growth hormone - LB03002 updates RSS · CI watch RSS
LG Life Sciences portfolio CI